Stockscreener 앱 받기
86.45
0.68%
-0.59
시장 영업 전:
87.90
1.45
+1.68%
전일 마감가:
$87.04
열려 있는:
$86.65
하루 거래량:
6.77M
Relative Volume:
0.69
시가총액:
$14.58B
수익:
$803.32M
순이익/손실:
$-709.10M
주가수익비율:
-11.08
EPS:
-7.8003
순현금흐름:
$-212.68M
1주 성능:
+10.61%
1개월 성능:
+17.17%
6개월 성능:
+73.35%
1년 성능:
+75.60%
1일 변동 폭
$83.01
$88.08
1주일 범위
$79.42
$91.06
52주 변동 폭
$31.36
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
TEM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
86.45 | 15.12B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
274.58 | 44.89B | 2.97B | 809.93M | 1.33B | 4.87 |
|
DOCS
Doximity Inc
|
72.67 | 13.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.28 | 7.89B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.59 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | H.C. Wainwright | Buy |
| 2025-04-21 | 개시 | BTIG Research | Buy |
| 2025-02-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 재개 | TD Cowen | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-09 | 개시 | Guggenheim | Buy |
| 2024-11-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Tempus AI, Inc. $TEM Shares Bought by Salem Investment Counselors Inc. - MarketBeat
Cathie Wood Bets on AMD, Bullish, and Figma; Trims Tempus AI, Roku - TipRanks
Tempus AI awarded $60.57M contract from Dept. of Health and Human Services - TipRanks
Why Cathie Wood Is Dumping This AI Healthcare Stock - TipRanks
An AI Fix for Healthcare's $2 Trillion Flaw - ETF Trends
NewEdge Advisors LLC Buys 35,098 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (NASDAQ:TEM) Price Target Raised to $98.00 - MarketBeat
13,690 Shares in Tempus AI, Inc. $TEM Purchased by Balefire LLC - MarketBeat
Strs Ohio Makes New $1.72 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Volume Report: Does Tempus AI Inc have pricing powerJuly 2025 Gainers & AI Driven Stock Movement Reports - خودرو بانک
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI - inkl
TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance - sharewise.com
Moderately bullish activity in tempus AI Inc Class A with shares up 1.64% - TipRanks
Cathie Wood sells $10.8 million of popular AI stock - TheStreet
Cathie Wood’s ARK ETF buys AMD and sells Tempus stock - Investing.com
Cathie Wood’s ARK ETF buys AMD and sells Tempus stock By Investing.com - Investing.com South Africa
Chart Watch: What is the next catalyst for Tempus AI IncWeekly Stock Report & Reliable Price Action Trade Plans - خودرو بانک
ARCT, TEM: Cathie Wood Expands Bet in Biotech, Trims Stake in Tempus AI Stock - TipRanks
Tempus AI Sees Unusually High Options Volume (NASDAQ:TEM) - MarketBeat
Arete Wealth Advisors LLC Buys Shares of 6,500 Tempus AI, Inc. $TEM - MarketBeat
Magnetic Resonance Imaging Devices Market Poised to Register a CAGR of ~6.54% by 2032 | DelveInsight - The Globe and Mail
Trading Recap: Can Tempus AI Inc. disrupt its industryAnalyst Downgrade & Fast Gain Stock Tips - خودرو بانک
Aug Update: Can Tempus AI Inc reach all time highs this yearWeekly Trade Summary & Weekly Chart Analysis and Guides - خودرو بانک
Mixed options sentiment in tempus AI Inc Class A with shares down 1.6% - TipRanks
What's Going On With Tempus AI Stock Monday? - Benzinga
Renalytix plc Announces Collaboration with Tempus AI, Inc. to Advance Intelligent Risk Assessment in Diabetic Kidney Disease - MarketScreener
Renalytix Signs Deal With Tempus AI To Avail KidneyintelX.dkd Prognostic Blood Testing In US - Nasdaq
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
0.49%
자본화:
|
볼륨(24시간):